German biopharmaceutical started phase 1 of clinical studies with CVnCoV in June 2020 at centers in Germany π©πͺ and Belgium π§πͺ.
Latin America - At the end of September 2020, clinical trial for phase 2 a in Peru π΅πͺ and Panama π΅π¦ began.
https://www.facebook.com/bajasearch/posts/3813388332007443